Indian Non-Invasive Prenatal Testing (NIPT) Market size is expected to reach USD 62 million by 2028. The market is expected to expand at a CAGR of more than 11% from 2022 to 2028.
India Non-Invasive Prenatal Testing Market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetuses, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing. The market shows high potential for growth in the future.
This new market report presents a comprehensive study of the entire Indian non-invasive prenatal testing market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the India non-invasive prenatal testing market. The report also provides up–to–date historical market size data for the period 2018-2021 and an illustrative forecast to 2028 covering key market aspects like market value and volume for non-invasive prenatal testing in India.
This Comprehensive India’s Non-Invasive Prenatal Testing Market Research Report Provides:
- To Analyse the Historical Growth in the Market Size of the India Non–Invasive Prenatal Testing Market from 2018 to 2021
- To Estimate and Forecast the Market Size of the India Non–Invasive Prenatal Testing Market from 2022 to 2028 and Growth Rate until 2028
- Evaluates the Number of NIPT Tests Performed in India with Six Years Forecast
- Assessment of Market Potential and Opportunities for this Innovation-Driven India Non–Invasive Prenatal Testing Market with Six Years Forecast
- Meticulously Assesses the Overall United States Potential Non–Invasive Prenatal Testing (NIPT) Volume and Future Trends
- Detailed Insights into the Regulatory Framework of the India Non–Invasive Prenatal Testing Market
- Features Reimbursement Patterns of the India Non–Invasive Prenatal Testing Market
- Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
- A Comprehensive List of the Key Players Along with the Analysis of their Current NIPT Test Portfolios, Business Overview, and Recent Development
The Leading Companies for the Indian Non-Invasive Prenatal Testing Market are Listed Below:
- Medgenome
- DNA Labs India
- LifeCell
- Apollo Centre for Fetal Medicine
- Igenomix India
- Fortis Healthcare Limited
- DNA Forensics Laboratory Pvt. Ltd.
- Thyrocare Technologies Limited
Key Questions Answered in this Report:
- What is the current scenario of the Indian non-invasive prenatal testing market?
- What is the total market size and forecast (until 2028) for the Indian non-invasive prenatal testing market?
- How has the potential Indian market performed so far and how will it perform in the coming years?
- How many NIPT tests were performed in India during 2018-2028?
- What are the key marketed NIPT tests available in India?
- What are the major drivers of the Indian non-invasive prenatal testing market?
- What are the major inhibitors of the Indian non-invasive prenatal testing market?
- What is the reimbursement pattern in the Indian non-invasive prenatal testing market?
- What is the regulatory framework in the Indian non-invasive prenatal testing market?
- What are the major deals and agreement happenings in the non-invasive prenatal testing market?
- Who are the top Indian market players? What are their happenings, current developments, and scenarios?
- How is the Indian market predicted to develop in the future?
Table of Contents
1. Executive Summary2. India Actual Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018-2028)3. India Potential Non-Invasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018-2028)4. India Actual Non-Invasive Prenatal Testing Market Size and Forecast (2018-2028)5. India Potential Non-Invasive Prenatal Testing Market Size and Forecast (2018-2028)6. India Non-Invasive Prenatal Testing Market Growth Drivers and Challenges7. Non-Invasive Prenatal Testing Comparative Analysis8. Reimbursement Environment of the India Non-Invasive Prenatal Testing Market9. Regulation Framework of the India Non-Invasive Prenatal Testing Market
Samples
LOADING...
Companies Mentioned
- Medgenome
- DNA Labs India
- LifeCell
- Apollo Centre for Fetal Medicine
- Igenomix India
- Fortis Healthcare Limited
- DNA Forensics Laboratory Pvt. Ltd.
- Thyrocare Technologies Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 65 |
| Published | January 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 28 Million |
| Forecasted Market Value ( USD | $ 62 Million |
| Compound Annual Growth Rate | 12.0% |
| Regions Covered | India |
| No. of Companies Mentioned | 8 |
